ACLX vs. OLMA

Last updated Apr 1, 2026

Compare and contrast key facts about Arcellx Inc (ACLX) and Olema Pharmaceuticals, Inc. (OLMA).

Performance

ACLX vs. OLMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcellx Inc (ACLX) and Olema Pharmaceuticals, Inc. (OLMA). The values are adjusted to include any dividend payments, if applicable.

ACLX vs. OLMA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
ACLX Arcellx Inc	76.10%	-14.98%	38.18%	79.15%	84.40%
OLMA Olema Pharmaceuticals, Inc.	-40.36%	328.82%	-58.45%	472.65%	-58.33%

Fundamentals

EPS ACLX : -$3.86 OLMA : -$1.75
Total Revenue (TTM) ACLX : $35.90M OLMA : $0.00
Gross Profit (TTM) ACLX : $810.00K OLMA : $0.00
EBITDA (TTM) ACLX : -$209.52M OLMA : -$161.30M

Returns By Period

In the year-to-date period, ACLX achieves a 76.10% return, which is significantly higher than OLMA's -40.36% return.

ACLX

• 1D: 0.04%
• 1M: 0.91%
• YTD: 76.10%
• 6M: 39.85%
• 1Y: 75.03%
• 3Y*: 55.04%
• 5Y*: —
• 10Y*: —

OLMA

• 1D: 11.10%
• 1M: -38.39%
• YTD: -40.36%
• 6M: 52.30%
• 1Y: 296.54%
• 3Y*: 62.57%
• 5Y*: -15.39%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ACLX vs. OLMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACLX

ACLX Risk / Return Rank: 80
ACLX Sharpe Ratio Rank: 70
ACLX Sortino Ratio Rank: 86
ACLX Omega Ratio Rank: 88
ACLX Calmar Ratio Rank: 78
ACLX Martin Ratio Rank: 77

OLMA

OLMA Risk / Return Rank: 93
OLMA Sharpe Ratio Rank: 89
OLMA Sortino Ratio Rank: 97
OLMA Omega Ratio Rank: 96
OLMA Calmar Ratio Rank: 91
OLMA Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACLX vs. OLMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcellx Inc (ACLX) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ACLX	OLMA	Difference
Sharpe ratio Return per unit of total volatility	0.83	1.84	-1.01
Sortino ratio Return per unit of downside risk	2.47	4.00	-1.54
Omega ratio Gain probability vs. loss probability	1.37	1.53	-0.16
Calmar ratio Return relative to maximum drawdown	2.09	4.20	-2.12
Martin ratio Return relative to average drawdown	4.96	11.00	-6.04
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ACLX vs. OLMA - Sharpe Ratio Comparison

The current ACLX Sharpe Ratio is 0.83, which is lower than the OLMA Sharpe Ratio of 1.84. The chart below compares the historical Sharpe Ratios of ACLX and OLMA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ACLX	OLMA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.83	1.84	-1.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.14	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.81	-0.19	+0.99

Correlation

The correlation between ACLX and OLMA is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ACLX vs. OLMA - Dividend Comparison

Neither ACLX nor OLMA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ACLX vs. OLMA - Drawdown Comparison

The maximum ACLX drawdown since its inception was -62.33%, smaller than the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for ACLX and OLMA.

Drawdown Indicators

	ACLX	OLMA	Difference
Max Drawdown Largest peak-to-trough decline	-62.33%	-96.26%	+33.93%
Max Drawdown (1Y) Largest decline over 1 year	-33.06%	-62.55%	+29.49%
Max Drawdown (5Y) Largest decline over 5 years	—	-94.36%	—
Current Drawdown Current decline from peak	0.00%	-72.64%	+72.64%
Average Drawdown Average peak-to-trough decline	-21.20%	-75.04%	+53.84%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.90%	23.88%	-9.98%

Volatility

ACLX vs. OLMA - Volatility Comparison

The current volatility for Arcellx Inc (ACLX) is 0.60%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 37.35%. This indicates that ACLX experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ACLX	OLMA	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.60%	37.35%	-36.75%
Volatility (6M) Calculated over the trailing 6-month period	65.53%	106.07%	-40.54%
Volatility (1Y) Calculated over the trailing 1-year period	91.09%	162.85%	-71.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	73.50%	108.49%	-34.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.50%	107.61%	-34.11%

Financials